Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in the treatment of major depression
IRCT201307181556N54Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of riluzole in major depressive disorder (MDD), sponsored by Tehran University of Medical Sciences. Started Aug 2013; status: completed.
02
Drugs
riluzole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201307181556N54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201307181556N54.